Bio surveillance to determine Prevalence of SARS-CoV-2 Specific Antibodies in UMMC Employees with Varying Exposure to COVID-19 Patients

About this Study

UMMC leadership has initiated a biosurveillance study to estimate the prevalence of CoV-2 antibodies among the UMMC community, both for those involved in the direct care of COVID-19 patients and for those not directly involved.

We are compiling a list of volunteers who will consent to having a blood draw to determine antibody presence.  From this list, we will randomly select roughly 800 participants to be included in the study.

*This study is for UMMC Employees Only.

Sponsor Protocol ID:2020-0172
IRB Number:2020-0172
Closed for Enrollment
Observational
Observational/Not Applicable
June 30, 2020
Eligibility Criteria
Both Male and Female
No
No
Yes
Categories Click category to view its trials.
COVID-19 (Coronavirus)
Participating Locations
University Hospital
Contact Information
Contact Name: Denise Montgomery
Phone Number: 601-815-5374
Email: ddmontgomery@umc.edu
Principal Investigator:Marshall, Gailen D, M.D.Ph.D., M.D., Ph.D.
How to participate in our Clinical Trials